Published Oct. 6, 2026. Jeffrey Archer, the bestselling British novelist and former Conservative politician, has died at age 86, his publisher confirmed. He died suddenly and peacefully at home between writing sessions, according to HarperCollins.
Archer’s death came one day before the planned publication of his final novel, Adam and Eve. He had continued meeting readers and promoting his work in the days before his death.
A global publishing career
Archer sold more than 300 million books during a writing career spanning five decades. His best-known novels include Not a Penny More, Not a Penny Less, Kane and Abel and the multi-volume Clifton Chronicles.
His novels were known for fast-moving plots, reversals and stories about ambition, power and social mobility. HarperCollins described him as a storyteller who maintained an unusually close relationship with his readers.
Politics, scandal and reinvention
Before becoming a full-time writer, Archer entered Britain’s Parliament in 1969. He later served as deputy chairman of the Conservative Party and spent more than three decades in the House of Lords before retiring in 2024.
His political career was repeatedly disrupted by controversy. In 2001, he was convicted of perjury and perverting the course of justice in connection with a libel case and served two years in prison. He later drew on that experience for a three-volume prison diary and continued publishing bestselling fiction.
Family and final book
Archer is survived by his wife, Dame Mary Archer, their two sons and five grandchildren. The couple marked their 60th wedding anniversary earlier in 2026.
The Associated Press reported that Adam and Eve was intended as his final novel. Archer had told his publisher from the project’s beginning that it would close his fiction career.
Follow AskNovus Entertainment for confirmed cultural and celebrity news.
Sources
- Associated Press, Oct. 6, 2026.
- Reuters, Oct. 5, 2026.
Featured image: Books on shelves in London. Photo by Ed Robertson on Unsplash. The image is illustrative.